HepATocellular Cancer Hcv Therapy Study

Clinical trial NCT04546802 · WITHDRAWN

Trial details

NCT number: NCT04546802
Sponsor: Bayside Health
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Hepatoma Liver Cell Carcinoma Hepatitis C

Start date: 2019-09-01
Primary completion: 2021-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.